Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood
Nicole E. DeAngeli, Travis P. Todd, Stephen E. Chang, et al.
Frontiers in Behavioral Neuroscience (2015) Vol. 8
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten, Ellen A. A. Nollen, Ute F. Röhrig, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 5, pp. 379-401
Open Access | Times Cited: 1129
The kynurenine pathway in schizophrenia and bipolar disorder
Sophie Erhardt, Lilly Schwieler, Sophie Imbeault, et al.
Neuropharmacology (2016) Vol. 112, pp. 297-306
Closed Access | Times Cited: 219
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer
Masaru Tanaka, Eleonóra Spekker, Ágnes Szabó, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 627-642
Closed Access | Times Cited: 77
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marta Marszałek‐Grabska, Katarzyna Walczak, Kinga Gaweł, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107845-107845
Open Access | Times Cited: 98
Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior
Francesca M. Notarangelo, Ana Pocivavsek
Neuropharmacology (2016) Vol. 112, pp. 275-285
Open Access | Times Cited: 84
Effects of Sleep Deprivation on the Tryptophan Metabolism
Abid Bhat, Ananda Staats Pires, Vanessa Tan, et al.
International Journal of Tryptophan Research (2020) Vol. 13
Open Access | Times Cited: 56
Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine
Caroline M. Forrest, Kara McNair, Mazura Pisar, et al.
Neuroscience (2015) Vol. 310, pp. 91-105
Open Access | Times Cited: 47
Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations
Livia De Picker, Erik Fransén, Violette Coppens, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 33
Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons
Klas R. Linderholm, Maximilian Tufvesson‐Alm, Markus K. Larsson, et al.
Neuropharmacology (2015) Vol. 102, pp. 42-47
Open Access | Times Cited: 39
Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice
Dániel Péter Varga, Judit Herédi, Zita Kánvási, et al.
Frontiers in Behavioral Neuroscience (2015) Vol. 9
Open Access | Times Cited: 35
Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia
Maximilian Tufvesson‐Alm, Lilly Schwieler, Robert Schwarcz, et al.
Neuropharmacology (2018) Vol. 138, pp. 130-139
Open Access | Times Cited: 32
Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice
Markus K. Larsson, Anthi Faka, Maria Bhat, et al.
Neurochemical Research (2016) Vol. 41, Iss. 9, pp. 2243-2255
Closed Access | Times Cited: 31
Dityrosine administration induces novel object recognition deficits in young adulthood mice
Yumei Ran, Biao Yan, Zhuqing Li, et al.
Physiology & Behavior (2016) Vol. 164, pp. 292-299
Closed Access | Times Cited: 30
Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding
Michelle Pershing, David Phenis, Valentina Valentini, et al.
Psychopharmacology (2016) Vol. 233, Iss. 21-22, pp. 3725-3735
Open Access | Times Cited: 27
N-Acetylcysteine Inhibits Kynurenine Aminotransferase II
Tonali Blanco Ayala, Korrapati V. Sathyasaikumar, Joachim D. Uys, et al.
Neuroscience (2020) Vol. 444, pp. 160-169
Open Access | Times Cited: 27
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
Ferenc Zádor, Gábor Nagy-Grócz, Gabriella Kékesi, et al.
Molecules (2019) Vol. 24, Iss. 20, pp. 3709-3709
Open Access | Times Cited: 26
Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid
Edén Flores-Barrera, Daniel R. Thomases, Daryn K. Cass, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 33, pp. 7921-7929
Open Access | Times Cited: 26
Astrocytes as Pharmacological Targets in the Treatment of Schizophrenia
Ana Pocivavsek, Francesca M. Notarangelo, Hui‐Qiu Wu, et al.
Handbook of behavioral neuroscience (2015), pp. 423-443
Closed Access | Times Cited: 26
Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice
Francesca M. Notarangelo, Sarah Beggiato, Robert Schwarcz
Developmental Neuroscience (2019) Vol. 41, Iss. 1-2, pp. 102-111
Open Access | Times Cited: 23
Kynurenine Pathway as a New Target of Cognitive Impairment Induced by Lead Toxicity During the Lactation
Daniela Ramírez Ortega, Paulina Ovalle Rodríguez, Benjamín Pineda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 23
Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood
Britta Hahn, Carolyn H. Reneski, Ana Pocivavsek, et al.
Psychopharmacology (2017) Vol. 235, Iss. 3, pp. 651-661
Open Access | Times Cited: 22
Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats
Francesca Frescura, Tibor Štark, Edoardo Tiziani, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 887-894
Closed Access | Times Cited: 2
Maternal protein restriction during gestation and lactation in the rat results in increased brain levels of kynurenine and kynurenic acid in their adult offspring
Paula Honório de Melo Martimiano, André de Sá Braga Oliveira, Véronique Ferchaud‐Roucher, et al.
Journal of Neurochemistry (2016) Vol. 140, Iss. 1, pp. 68-81
Open Access | Times Cited: 19
Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence
Sarah Beggiato, Alessandro Ieraci, Mariachiara Zuccarini, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 10
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Jens O. Watzlawik, Bharath Wootla, Moses Rodriguez
Current Pharmaceutical Design (2015) Vol. 22, Iss. 8, pp. 1049-1059
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top